Literature DB >> 15184884

Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers.

Jane E Armes1, Fleur Hammet, Melanie de Silva, John Ciciulla, Susan J Ramus, Wee-Kheng Soo, Alexis Mahoney, Natalia Yarovaya, Michael A Henderson, Kurt Gish, Anne-Marie Hutchins, Gareth R Price, Deon J Venter.   

Abstract

Loss of genetic material from chromosome arm 8p occurs commonly in breast carcinomas, suggesting that this region is the site of one or more tumor-suppressor genes (TSGs). Comparative genomic hybridization analysis showed that 8p loss is more common in breast cancers from pre-menopausal compared with post-menopausal patients, as well as in high-grade breast cancers, regardless of the menopausal status. Subsequent high-resolution gene expression profiling of genes mapped to chromosome arm 8p, on an extended cohort of clinical tumor samples, indicated a similar dichotomy of breast cancer clinicopathologic types. Some of these genes showed differential downregulation in early-onset and later-onset, high-grade cancers compared with lower-grade, later-onset cancers. Three such genes were analysed further by in situ technologies, performed on tissue microarrays representing breast tumor and normal tissue samples. PCM1, which encodes a centrosomal protein, and DUSP4/MKP-2, which encodes a MAP kinase phosphatase, both showed frequent gene and protein loss in carcinomas. In contrast, there was an excess of cases showing loss of expression in the absence of reduced gene copy number of SFRP1, which encodes a dominant-negative receptor for Wnt-family ligands. These candidate TSGs may constitute some of the molecular drivers of chromosome arm 8p loss in breast carcinogenesis. Copyright 2004 Nature Publishing Group

Entities:  

Mesh:

Year:  2004        PMID: 15184884     DOI: 10.1038/sj.onc.1207740

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  42 in total

1.  Detection of inherited mutations for hereditary cancer using target enrichment and next generation sequencing.

Authors:  Yanfang Guan; Hong Hu; Yin Peng; Yuhua Gong; Yuting Yi; Libin Shao; Tengfei Liu; Gairui Li; Rongjiao Wang; Pingping Dai; Yves-Jean Bignon; Zhe Xiao; Ling Yang; Feng Mu; Liang Xiao; Zeming Xie; Wenhui Yan; Nan Xu; Dongxian Zhou; Xin Yi
Journal:  Fam Cancer       Date:  2015-03       Impact factor: 2.375

2.  Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer.

Authors:  Ruben Agrelo; Wen-Hsing Cheng; Fernando Setien; Santiago Ropero; Jesus Espada; Mario F Fraga; Michel Herranz; Maria F Paz; Montserrat Sanchez-Cespedes; Maria Jesus Artiga; David Guerrero; Antoni Castells; Cayetano von Kobbe; Vilhelm A Bohr; Manel Esteller
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-24       Impact factor: 11.205

3.  Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype-negative colon cancer.

Authors:  Lenora W M Loo; Maarit Tiirikainen; Iona Cheng; Annette Lum-Jones; Ann Seifried; James M Church; Robert Gryfe; Daniel J Weisenberger; Noralane M Lindor; Steven Gallinger; Robert W Haile; David J Duggan; Stephen N Thibodeau; Graham Casey; Loïc Le Marchand
Journal:  Genes Chromosomes Cancer       Date:  2013-01-23       Impact factor: 5.006

4.  Epigenetic inactivation of the SFRP1 gene in esophageal squamous cell carcinoma.

Authors:  Ying Meng; Qing-Gang Wang; Jun-Xiong Wang; Sheng-tao Zhu; Yue Jiao; Peng Li; Shu-tian Zhang
Journal:  Dig Dis Sci       Date:  2011-05-13       Impact factor: 3.199

5.  Use of integrative epigenetic and cytogenetic analyses to identify novel tumor-suppressor genes in malignant melanoma.

Authors:  Suhail K Mithani; Ian M Smith; Joseph A Califano
Journal:  Melanoma Res       Date:  2011-08       Impact factor: 3.599

Review 6.  Inside the human cancer tyrosine phosphatome.

Authors:  Sofi G Julien; Nadia Dubé; Serge Hardy; Michel L Tremblay
Journal:  Nat Rev Cancer       Date:  2011-01       Impact factor: 60.716

7.  8p deletion is strongly linked to poor prognosis in breast cancer.

Authors:  P Lebok; A Mittenzwei; M Kluth; C Özden; B Taskin; K Hussein; K Möller; A Hartmann; A Lebeau; I Witzel; S Mahner; L Wölber; F Jänicke; S Geist; P Paluchowski; C Wilke; U Heilenkötter; R Simon; G Sauter; L Terracciano; R Krech; A von der Assen; V Müller; E Burandt
Journal:  Cancer Biol Ther       Date:  2015-05-11       Impact factor: 4.742

8.  WRN Cys1367Arg SNP is not associated with risk and prognosis of gliomas in Southeast Brazil.

Authors:  Giovanny R Pinto; France K N Yoshioka; Carlos A Clara; Marcelo J Santos; José R W Almeida; Rommel R Burbano; Juan A Rey; Cacilda Casartelli
Journal:  J Neurooncol       Date:  2008-08-01       Impact factor: 4.130

9.  Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer.

Authors:  Justin M Balko; Luis J Schwarz; Neil E Bhola; Richard Kurupi; Phillip Owens; Todd W Miller; Henry Gómez; Rebecca S Cook; Carlos L Arteaga
Journal:  Cancer Res       Date:  2013-08-21       Impact factor: 12.701

10.  An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors.

Authors:  D Chitale; Y Gong; B S Taylor; S Broderick; C Brennan; R Somwar; B Golas; L Wang; N Motoi; J Szoke; J M Reinersman; J Major; C Sander; V E Seshan; M F Zakowski; V Rusch; W Pao; W Gerald; M Ladanyi
Journal:  Oncogene       Date:  2009-06-15       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.